Eris Lifesciences, Biocon: Eris Lifesciences, a company specializing in branded formulations, is set to buy the domestic branded formulation business of ...

Following the release of Biocon's Q2FY24 results, domestic brokerage firms offer mixed opinions on the stock, with varying recommendations based on the ...

On November 9, the attention of investors will be on the shares of Biocon and Eris Lifesciences as Biocon's subsidiary, Biocon Biologics, prepares to divest ...

Catch a glimpse of the market movers ahead of the opening bell on November 9, 2023:Biocon: Biocon Biologics, a subsidiary of Biocon, has inked a ...

Phillip Capital has provided positive insights into the Indian pharmaceutical industry, projecting gains from the ongoing benefits of gRevlimid, softening ...

As the trading day unfolds, investors and market enthusiasts are keeping a close eye on several key stocks poised to make headlines:1. HDFC Bank: The ...